Senior Director, Regulatory Affairs, Pulmovant

Pulmovant

United States

Remote

USD 260,000 - 380,000

Full time

14 days+

Get a reply from this employer

Your resume and cover letter, tailored to exactly what they’re hiring for.

Get past ATS filters

Job summary

Pulmovant seeks a Senior Director of Regulatory Affairs to lead global regulatory strategy and ensure timely, compliant submissions for pulmonary programs. You will manage interactions with the FDA and other global health authorities, oversee NDA/MAA submissions, and guide cross-functional teams through development to approval.

The role demands extensive regulatory leadership, deep experience with US and international requirements, and a proactive approach to risk management and dossier

Qualifications

  • 15+ years of regulatory affairs experience with leadership roles.
  • Experience leading NDA submissions and interactions with health authorities.
  • Experience with global regulatory requirements (FDA, EMA, PMDA, ICH).

Responsibilities

  • Provide global regulatory strategy and leadership across development programs.
  • Lead submissions to health authorities (IND/CTA, NDA/BLA) and interactions with regulators.
  • Coordinate with CROs and internal stakeholders to ensure compliant filings and timelines.
  • Monitor regulatory developments and advise on potential impact to programs.
  • Mentor and supervise junior regulatory staff and cross-functional teams.

Skills

Regulatory strategy
FDA experience
Cross-functional leadership
Clinical development
GxP awareness

Education

BS in scientific field
MS in scientific field
PhD/PharmD in scientific field

Job description

Senior Director, Regulatory Affairs, Pulmovant

Remote, US

Pulmovant is a Roivant-backed clinical-stage biotechnology company committed to transforming the lives of patients with pulmonary diseases. Pulmovant’s first investigational candidate, mosliciguat, is designed to provide a novel, once-daily, inhaled treatment option for patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD). Mosliciguat is a potential first-in-class soluble guanylate cyclase activator with a differentiated mechanism of action currently being evaluated in the Phase 3 PHrontier global clinical trial in PH-ILD, but with potential broad applicability across the PH and ILD disease landscape.

Pulmovant recently announced positive results from its Phase 2 PHocus study evaluating mosliciguat for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), a progressive and life-threatening condition with significant unmet medical needs for patients. PHocus met both primary and secondary endpoints including the highest ever reported pulmonary vascular resistance (PVR) reduction in any randomized controlled PH trial. The robust results, in conjunction with mosliciguat’s once-daily, inhaled administration and potential first-in-class sGC activator profile, strongly position it as a potentialsingle agent treatment and combination therapy for patients with PH-ILD.These data represent a significant advancement in a devastating disease that affects ~200,000 patients with no or very limited treatment options. A Phase 3 trial is currently underway.More details can be found in the press release here .

As part of the Roivant family of companies, Pulmovant leverages the power of collaboration and innovation to drive progress.

Roivant (Nasdaq: ROIV) is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. Roivant’s pipeline includes LISRAYA™ (brepocitinib), a potent small molecule inhibitor of JAK1 and TYK2 FDA-approved for the treatment of dermatomyositis in adult patients and also in late-stage development for the treatment of non‑infectious uveitis, cutaneous sarcoidosis and lichen planopilaris; IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG‑mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. For more information, visit www.roivant.com .

Position: Senior Director,Regulatory Affairs

Summary

The Senior Director of Regulatory Affairs is responsible for providing global regulatory strategy and support as a member of multi‑disciplinary teams. Manage the process from development through to approval and ensure compliance with all US and international regulatory requirements.

KeyDuties and Responsibilities
  • Represent Regulatory Affairs in assigned project meetings and provide regulatory guidance to cross‑functional project teams as appropriate; leverage experience in regulatory affairs to provide guidance to colleagues for preparation of regulatory documents
  • Serve as regulatory affairs contact for external parties (for example, CROs, advisors) involved in the conduct of Pulmovant’s global clinical trials
  • Develop and implement a global regulatory strategy for submissions to support clinical trials and registration in accordance with applicable regulations/guidelines (for example, US FDA, EMA, PMDA, ICH, ISO)
  • Plan, prepare, author, and/or review documentation and submissions (for example, IND, CTA, BLA, NDA, MAA) to health authorities to support clinical trials, registration, maintenance of registration, and labeling of pharmaceutical products
  • Liaise with global health authorities as needed
  • Contribute to the development of competitive regulatory strategies that expedite development, maximize the probability of success, and mitigate risks
  • Communicate project updates and risks to senior regulatory affairs management and stakeholders across the organization
  • Tracking regulatory commitments and deliverables while coordinating with internal and external staff to ensure timely submissions
  • Coordinate and prepare responses to requests for information from health authorities
  • Prepare meeting requests, briefing documents, and coordinate and prepare teams for meetings with health authorities
  • Provide input into the development of internal policy and procedures for regulatory affairs in alignment with GxPs, guidance documents, and corporate objectives
  • Monitor, analyze, and disseminate intelligence on regulatory matters that may affect ongoing development programs
  • Participate in due diligence evaluations of potential in‑license/partnering opportunities
Education and Experience
  • Education equivalent to a BS degree in a scientific field, plus 15+ years of experience in regulatory affairs; or
  • Education equivalent to a MS degree in a scientific field, plus 12-15 years of experience in regulatory affairs; or
  • Education equivalent to a PhD/PharmD degree in a scientific field, plus 8 years of experience in regulatory affairs
  • Recent experience leading the preparation, submission and approval process for an NDA
  • Experience working with the FDA is essential. Additional experience with EU, Japan and other global HAs is strongly preferred.
  • Experience interacting with the FDA Division of Cardiology and Nephrology strongly preferred
  • Experience with pulmonary hypertension and other pulmonary diseases a plus
  • Experience in drug/device combination products a plus
  • Regulatory Affairs Certification (RAC) in drugs and/or devices a plus
EssentialSkills andAbilities
  • Unquestionable integrity, being able to inspire trust, and exhibit the highest ethical standards
  • Excellent communication, verbal and written, and interpersonal skills with a strong ability to interact with internal teams and partners across all levels of the organization
  • Ability to effectively present information and respond to questions from all levels of the organization
  • Sense of urgency, flawless execution with intense focus on accuracy and accountability
  • Self‑starter, highly motivated, assertive, driven, and hands‑on leader
  • Ability to multi‑task in a fast‑paced environment
Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

Associate Director, Drug Product, Pulmovant
Associate Director, Drug Product, Pulmovant

Pulmovant • United States

Remote
USD 180,000 - 230,000
Senior Manager / Associate Director, CMC Project Management, Pulmovant
Senior Manager / Associate Director, CMC Project Management, Pulmovant

Pulmovant • United States

Remote
USD 140,000 - 210,000
Executive Assistant, Pulmovant
Executive Assistant, Pulmovant

Pulmovant • United States

Remote
USD 90,000 - 120,000
Manager, CMC Quality, Pulmovant
Manager, CMC Quality, Pulmovant

Pulmovant • United States

Remote
USD 120,000 - 180,000
Head of Analytical Development, Pulmovant
Head of Analytical Development, Pulmovant

Pulmovant • United States

Remote
USD 200,000 - 300,000
Director, Biostatistics, Pulmovant
Director, Biostatistics, Pulmovant

Pulmovant • United States

Remote
USD 180,000 - 260,000
Associate Director, Drug Substance, Pulmovant
Associate Director, Drug Substance, Pulmovant

Pulmovant • United States

Remote
USD 150,000 - 210,000
Manager/Senior Manager, Statistical Programming, Pulmovant
Manager/Senior Manager, Statistical Programming, Pulmovant

Pulmovant • United States

On-site
USD 140,000 - 200,000
Manager/Senior Manager, Statistical Programming, Pulmovant New Remote, US
Manager/Senior Manager, Statistical Programming, Pulmovant New Remote, US

Pulmovant • United States

Remote
USD 140,000 - 230,000
Senior Manager, Regulatory Affairs
Senior Manager, Regulatory Affairs

Liquidia Technologies • United States

On-site
USD 120,000 - 180,000